-
Mashup Score: 5Scientific Sessions OnDemand™ - 1 year(s) ago
Watch top science presentations and discussions from Scientific Sessions 2022 at your leisure. Save up to $200 on your purchase by becoming an AHA Member!
Source: professional.heart.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Scientific Sessions OnDemand™ - 1 year(s) ago
Watch top science presentations and discussions from Scientific Sessions 2022 at your leisure. Save up to $200 on your purchase by becoming an AHA Member!
Source: professional.heart.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1AHA Late-Breaker: OCEAN(a)-DOSE – Reduction of Lipoprotein(a) With Small Interfering RNA - American College of Cardiology - 1 year(s) ago
Although lipoprotein(a) is believed to play a causal role in atherogenesis, there are no approved therapies to help lower it. The OCEAN(a) DOSE study examined a drug specifically designed to lower lipoprotein(a) through RNA interference. In this interview, Michelle L. O’Donoghue MD, MPH and Nanette Kass Wenger MD, MACC discuss AHA Late-Breaker: OCEAN(a)-DOSE – Reduction of Lipoprotein(a) With…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The Take Home: AHA Scientific Sessions - 1 year(s) ago
The American Heart Association Scientific Sessions were held Nov. 5 to 7 in Chicago, the first time they were conducted in-person since 2019.Healio and Cardiology Today covered the meeting on-site and spoke to a number of key opinion leaders — including Geoffrey Barnes, MD, MSc, from the University of Michigan; Cardiology Today Prevention Section Editor Roger S. Blumenthal, MD, from the
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The Take Home: AHA Scientific Sessions - 1 year(s) ago
The American Heart Association Scientific Sessions were held Nov. 5 to 7 in Chicago, the first time they were conducted in-person since 2019.Healio and Cardiology Today covered the meeting on-site and spoke to a number of key opinion leaders — including Geoffrey Barnes, MD, MSc, from the University of Michigan; Cardiology Today Prevention Section Editor Roger S. Blumenthal, MD, from the
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The Take Home: AHA Scientific Sessions - 1 year(s) ago
The American Heart Association Scientific Sessions were held Nov. 5 to 7 in Chicago, the first time they were conducted in-person since 2019.Healio and Cardiology Today covered the meeting on-site and spoke to a number of key opinion leaders — including Geoffrey Barnes, MD, MSc, from the University of Michigan; Cardiology Today Prevention Section Editor Roger S. Blumenthal, MD, from the
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8
Original Article from The New England Journal of Medicine — Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia
Source: New England Journal of MedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 2VIDEO: Assessing cardiotoxicity in pediatric cancer patients - 1 year(s) ago
“About 85% of children with cancer survive, but the next question is how they can survive healthy in adult life,” Tsuda said. “Even those children who are quite healthy in childhood can develop long-term cardiac-toxicity disorder, including stroke, decades after their cancer.” He said often the toxicity can cause very serious and irreversible cardiac issues for the patient later in life. These…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VIDEO: Assessing TAVR valve durability - 1 year(s) ago
With the TAVR trials over the past decade came systematic, apples-to-apples, annual followup with echo to assess the valves, both surgical and TAVR. “Out to five years, the newest generation valves are performing every bit as well as surgery, and in some cases are indicating a lower risk of structural valve degeneration,” Lindman explained. As TAVR now makes up more than 80% aortic valve…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VIDEO: The need to develop the cardiology workforce - 1 year(s) ago
There is already a growing shortage of cardiologists, as well as other specialities, across the U.S. This has been made up largely by doctors from other countries who immigrate to the U.S. to fill open jobs. This shortage has been aggravated in the past year or so by many cardiologists re-evaluating their lives and jobs during the COVID-19 pandemic as part of the “great resignation” and moving to…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
RT @AHAScience: Experience #AHA22 late-breaking science anytime, anywhere with Scientific Sessions OnDemand. https://t.co/52iZNxIfcn